Company Dynamic

Dow’s Performance Silicones Business is raising prices in Greater China by approximately 5–10%, effective April 20, 2025, or as permitted by existing contracts.

Prinova, an ingredient company under the Nagase Group, recently completed the strategic acquisition of Brazilian specialty ingredient company Aplinova. This is another key layout in the Latin American market after the acquisition of Flavor Tec in 2023.

• Prinova
• Aplinova

On April 15, 2025, the Prescription Medicines Code of Practice Authority (PMCPA) determined that GlaxoSmithKline (GSK) breached ethical and regulatory standards concerning its drug Omjjara.

On April 15, BOE Technology Group released its 2024 earnings preview, revealing a revenue jump of 13.66% to 198.38 billion yuan, while net profit soared 108.97% to 5.32 billion yuan.

Wanhua Chemical’s latest financial update signals mounting pressure amid a cooling market. In Q1 2025, the company reported revenue of 43.07 billion yuan, reflecting a 6.7% drop year-on-year.

On April 14, BASF unveiled a major investment plan worth nearly 500 million yuan to build a second production line for its Cellasto polyurethane vibration damping components in Shanghai.

The breakthrough process involves calibrating the company’s Interpon powder coating formulations using IPG’s laser curing solutions for optimal results.

• AkzoNobel
• IPG

Wanhua Chemical released its 2024 annual and Q1 2025 reports on April 15, revealing a mixed financial picture. The company achieved 182.07 billion yuan in revenue in 2024, marking a 3.83% year-on-year increase.

AstraZeneca Pharma India has voluntarily surrendered its marketing authorization for Olaparib tablets (100mg and 150mg) used in treating patients with germline BRCA-mutated (gBRCA) advanced ovarian and breast cancer who have undergone three or more lines

GlaxoSmithKline (GSK) is under serious scrutiny after a UK pharmaceutical watchdog determined the company violated industry standards by promoting inaccurate prescription information for its blood disorder drug Omjjara.

Cellasto, a polyurethane damping component manufacturer under BASF, invested about 6 million euros to build its second plant in Shanghai, China.

• Cellasto
• BASF
• China

On April 10, 2025, Wanhua Chemical successfully acquired the specialty isocyanate business of France’s Vencorex, including its 70,000-ton HDI monomer production base near Grenoble.

Swiss pharmaceutical giant Roche has announced that its blood cancer drug Columvi, in combination with gemcitabine and oxaliplatin (GemOx)

LyondellBasell (LYB) has entered into a one-year agreement to use 100% renewable electricity at its manufacturing facility in Dalian by 2025.

• LyondellBasell
• renewable electricity

Saudi Aramco and Sinopec recently announced the signing of a joint venture framework agreement to pave the way for the expansion of their joint venture, Yanbu Refinery.

• Saudi Aramco
• Sinopec
• Yanbu Refinery

Despite industry headwinds, Lanxess defied the global slowdown, posting €6.14 billion in 2024 sales and a 19.9% jump in EBITDA—a performance that showcases the company’s strategic agility and shift toward specialty chemicals.

Pfizer has announced the cessation of its once-daily oral weight-loss drug, danuglipron, following a reported case of potential drug-induced liver injury during clinical trials.

Swiss pharmaceutical company Sandoz has initiated a legal battle against U.S. biotech giant Amgen, accusing it of unlawfully maintaining a monopoly over the arthritis medication Enbrel (etanercept).

Dutch coatings giant AkzoNobel is expanding its partnership with global lighting leader Signify. In the future, AkzoNobel will continue to supply Interpon F powder coatings for Philips LED outdoor luminaires.

• AkzoNobel
• Signify

IFF, a global supplier of flavors, fragrances, food and health ingredients, has partnered with Florida Polytechnic University to create a Citrus Innovation Center in Lakeland, Florida.

• IFF
• Citrus Innovation Center